Article

New risk calculator helps physicians with risk assessment

A recent study published in Archives of Ophthalmology validates a glaucoma risk calculator modeled on those used for cardiovascular disease.

Chicago-A recent study published in Archives of Ophthalmology validates a glaucoma risk calculator modeled on those used for cardiovascular disease (CVD). “It’s here, it’s now, and I think it will influence our treatment,” said Robert D. Fechtner, MD, FACS, professor of ophthalmology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School.

Similar to the calculators honed over the years to help physicians and patients estimate the risk of CVD and sudden death, the glaucoma calculator compiles numerous risk factors and assigns numerical value to them, with lower scores indicating lowest risk of an individual converting from ocular hypertension to glaucoma over the next 5 years.

The risk calculator is based on data collected in the Ocular Hypertension Treatment Study and is another tool physicians can use to help with treatment decisions, Dr. Fechtner said.

He explained that while physicians have become adept at determining a patient’s place on the glaucoma continuum, they lack a “radar gun” that can pinpoint the speed at which progression is occurring. With baseline data and regular follow-up using the risk calculator, physicians may be able to better estimate progression, Dr. Fechtner said.

Results of the calculation will be another piece of information useful in patient management.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.